|
Status |
Public on Apr 17, 2023 |
Title |
SUM159 + pLV-KRAB + gRNA4, biol rep 3 |
Sample type |
SRA |
|
|
Source name |
SUM159
|
Organism |
Homo sapiens |
Characteristics |
cell line: SUM159 cell type: Triple negative breast cancer transduction (vector): pLV-KRAB transduction (grna): gRNA #4 (vs ZEB1 promoter) sequencing run: run 1
|
Treatment protocol |
Lentiviral particles were produced using HEK293T with co-transfection using third generation VSVG (Addgene plasmid #12259), GAG/POL (Addgene plasmid #12260) and pLV dCas9-KRAB +/-gRNA as previously described [doi:10.1039/c9sc01432b & 10.1016/j.omtn.2018.12.003]. Four days following transduction, 1.25 µg/mL and 0.75 µg/mL puromycin was used to select SUM159 and MDA-MB-231, respectively.
|
Growth protocol |
SUM159 cells were cultured in F12 Medium supplemented with 0.6% 1M Hepes, 5 µg/mL insulin, 1 µg/mL hydrocortisone, 1% Antibiotic-Antimycotic and 10% heat inactivated FBS; MDA-MB-231 cells were cultured in DMEM-Hi glucose-pyruvate + 10% heat inactivated FBS, 1% Antibiotic-Antimycotic.
|
Extracted molecule |
total RNA |
Extraction protocol |
Cells were washed twices before RNA was harvested using QIZsol Lysis reagent (QIAGEN). Approximately 1 ug of total RNA was used for the construction of sequencing libraries. RNA libraries for RNA-seq were prepared by Australian Genome Research Facility, where libraries were preprared sequenced for 50bp single-end (SE) reads on the Illumina HiSeq 2500 system
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Description |
B1_SUM159_g4_3
|
Data processing |
RNA-seq data underwent pseudo-alignment and quantification with Salmon [10.1038/nmeth.4197] before import into R/Bioconductor using tximport [10.12688/f1000research.7563.2] Assembly: GRCh38 Supplementary files format and content: Comma separated text files including length-scaled TPM values for each sample
|
|
|
Submission date |
Aug 01, 2022 |
Last update date |
Apr 17, 2023 |
Contact name |
Joe Cursons |
Organization name |
Monash University
|
Department |
Biomedicine Discovery Institute
|
Street address |
19 Innovation Walk
|
City |
Clayton |
State/province |
VIC |
ZIP/Postal code |
3800 |
Country |
Australia |
|
|
Platform ID |
GPL16791 |
Series (2) |
GSE210274 |
Synthetic epigenetic reprogramming of mesenchymal to epithelial states using the CRISPR/dCas9 platform in triple negative breast cancer [RNA-seq] |
GSE210277 |
Synthetic epigenetic reprogramming of mesenchymal to epithelial states using the CRISPR/dCas9 platform in triple negative breast cancer |
|
Relations |
BioSample |
SAMN30088382 |
SRA |
SRX16760919 |